The most common alteration among ccRCC was VHL (78%, n = 396), which was associated with lower FAS/pentose phosphate signature scores (mean Z score difference, –0.15 compared with VHL wild-type tumors; P < 0.05) (Figure 3A). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.